| ²é¿´: 370 | »Ø¸´: 2 | ||
ÇåÐÂÄûÃÊË®½ð³æ (СÓÐÃûÆø)
|
[ÇóÖú]
Ôõô·Òë°¡
|
| What are the safety or efficacy issues, if any, for BE studies that fail to meet the 90% CI using equivalence limits of 80-125%? |
» ²ÂÄãϲ»¶
ÉúÎïѧ303Çóµ÷¼Á£¬Ò»Ö¾Ô¸»ªÖÐũ΢ÉúÎÁù¼¶Òѹý£¬ÓпÆÑÐÓÐÎÄÕ£¬µ³Ô±
ÒѾÓÐ3È˻ظ´
Çóµ÷¼Á
ÒѾÓÐ8È˻ظ´
Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
353Çóµ÷¼Á
ÒѾÓÐ10È˻ظ´
298Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
ÉúÎïѧ308·ÖÇóµ÷¼Á£¨Ò»Ö¾Ô¸»ª¶«Ê¦´ó£©
ÒѾÓÐ5È˻ظ´
Ò»Ö¾Ô¸µç×ӿƼ¼´óѧ085600²ÄÁÏÓ뻯¹¤ 329·ÖÇóµ÷¼Á
ÒѾÓÐ9È˻ظ´
284Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
0817»¯Ñ§¹¤³ÌÓë¼¼ÊõÇóµ÷¼Á£¬Ò»Ö¾Ô¸Öк£Ñó319
ÒѾÓÐ11È˻ظ´
304Çóµ÷¼Á£¨085602£¬¹ýËļ¶£¬Ò»Ö¾Ô¸985£©
ÒѾÓÐ12È˻ظ´
ssssllllnnnn
ÖÁ×ðľ³æ (ÖªÃû×÷¼Ò)
Translator and Proofreader
- ·ÒëEPI: 1690
- Ó¦Öú: 452 (˶ʿ)
- ½ð±Ò: 31580.9
- ºì»¨: 100
- Ìû×Ó: 7681
- ÔÚÏß: 19966.6Сʱ
- ³æºÅ: 3328089
- ×¢²á: 2014-07-17
- רҵ: Ö×Áö·¢Éú
2Â¥2014-10-23 19:28:15
ÇåÐÂÄûÃÊË®
½ð³æ (СÓÐÃûÆø)
- Ó¦Öú: 17 (СѧÉú)
- ½ð±Ò: 2685.1
- É¢½ð: 32
- ºì»¨: 2
- Ìû×Ó: 190
- ÔÚÏß: 230.1Сʱ
- ³æºÅ: 3036123
- ×¢²á: 2014-03-10
- ÐÔ±ð: MM
- רҵ: Ò©Îï´úлÓëÒ©ÎﶯÁ¦Ñ§
3Â¥2014-10-23 20:05:35














»Ø¸´´ËÂ¥